The Council of Employee Benefits Executives Advisory Committee is a standing committee of The Council and represents the benefits business interests of The Council member firms.
Healthcare In Transition | Aug. 14, 2019 | Access to Care, Government Affairs, Healthcare, Healthcare costs, Payment reform, Surprise Medical Billing August 15, 2019 The Council joined over 60 other employer groups on a letter to all Members of Congress urging them to pass the Lower Health Care Costs Act, which
Healthcare In Transition | Aug. 14, 2019 | Employer Sponsored Insurance, Healthcare, Healthcare costs, Pharmacy supply chain, Prescription Drug Pricing, Pricing transparency August 15, 2019 On the eve of the 2018 midterm elections, President Trump unveiled a new part of his “American Patients First” ideology, spurred by the difference in prices Americans
Healthcare In Transition | Aug. 14, 2019 | Access to Care, Healthcare, Healthcare costs, Payment reform, Social Determinants of Health August 15, 2019 Social Determinants of Health (SDOH) is a new industry buzzword, but it’s also a concept that’s existed for decades. Now it’s making its way into policy agenda
Healthcare In Transition | Jul. 17, 2019 | Access to Care, Employer Sponsored Insurance, Healthcare, Healthcare costs, Healthcare data July 18, 2019 Flock is a benefits administration, compliance and HR platform created with the goal of engaging employees and streamlining the benefits administration process. We sat down with Raj
Healthcare In Transition | Jul. 17, 2019 | Government Affairs, Healthcare, Healthcare costs, Healthcare reform, Payment reform, Prescription Drug Pricing, Pricing transparency July 18, 2019 President Trump announced the administration’s intention to release an executive order based on a “favored nations” clause. This approach suggests the U.S. would pay for pharmaceuticals at
Healthcare In Transition | Jul. 17, 2019 | Association health plans, Government Affairs, Healthcare, Healthcare reform, Pricing transparency, Short term health plan June 18, 2019 The White House recently released an executive order aimed at requiring insurers, physicians and hospitals to provide patients with more digestible information about the cost of their
Healthcare In Transition | Jul. 17, 2019 | Access to Care, Government Affairs, Healthcare, Healthcare costs, Healthcare reform, Payment reform, PBM, Prescription Drug Pricing, Surprise Medical Billing July 18, 2019 The Council recently expressed strong support for the Lower Health Care Costs Act, which confronts some of the biggest obstacles to bringing costs down in the healthcare
Healthcare In Transition | Jul. 17, 2019 | Access to Care, Government Affairs, Healthcare, Healthcare costs, Healthcare reform, Payment reform, PBM, Prescription Drug Pricing, Surprise Medical Billing July 18, 2019 The House Energy and Commerce Committee’s Subcommittee on Health recently marked up and voted in favor of drug transparency and surprise billing legislation. No Surprises Act (H.R.
Healthcare In Transition | Jul. 17, 2019 | Government Affairs, Healthcare costs, Payment reform, PBM, Prescription Drug Pricing July 18, 2019 The Trump administration announced it will not pursue its proposal to eliminate prescription drug rebates from government-facilitated health plans. While once touted as a critical step in
Healthcare In Transition | Jul. 17, 2019 | Cadillac Tax, Employer Sponsored Insurance, Government Affairs, Healthcare, Healthcare costs, Payment reform July 18, 2019 The Council has long supported efforts to repeal the Cadillac Tax, and now lawmakers are primed to do just that. The House passed a bill to repeal
